Task: Answer the MCQ question.
Query: Which compound exhibits a -14.412% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COc1cccc(NC(=O)CN(C)C(=O)CC2CC3CCC2C3)c1
b.) CC1(C)OC(=O)N(c2ccccc2)C12C=Cc1cc(Br)ccc1O2
Answer: b. CC1(C)OC(=O)N(c2ccccc2)C12C=Cc1cc(Br)ccc1O2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)OC(=O)N(c2ccccc2)C12C=Cc1cc(Br)ccc1O2
CC1(C)OC(=O)N(c2ccccc2)C12C=Cc1cc(Br)ccc1O2
6'-bromo-5,5-dimethyl-3-phenylspiro[1,3-oxazolidine-4,2'-chromene]-2-one